Plunkett Research Online: miRagen Therapeutics Inc

MIRAGEN THERAPEUTICS INC (MGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics. The company’s main product candidates, MRG-106, MRG-201, MRG-107, and MRG-110. MRG-106 and MRG-201 are currently in Phase 1 clinical tr.....



miRagen Therapeutics Inc
Ticker: MGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212 486-0040
Fax: 212 319-3328
Address: 6200 Lookout Road
Boulder, CO 80301 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Laboratories
ContactsDescription
William MarshallCEO/Director/President
Jason LeveroneCFO/Chief Accounting Officer/Secretary/Treasurer
See More
Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics. The company’s main product candidates, MRG-106, MRG-201, MRG-107, and MRG-110. MRG-106 and MRG-201 are currently in Phase 1 clinical tr.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: